FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage
The decision that will eventually bar compounding pharmacies from making unbranded versions of the injection. Source link
Read More
Biotech and Pharmaceuticals
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion
Read More
Health-care stocks fall as lawmakers, patients push for changes to their business models
The stock reaction on Wednesday appeared to be in response to new bipartisan legislation that aims to break up pharmacy
Read More
Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS
Shares of Moderna, Novavax, Pfizer, BioNTech and GSK closed lower on Thursday. Source link
Read More
Novo Nordisk’s diabetes drug Ozempic may reduce the risk of Alzheimer’s disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in
Read More
Drug costs, abortion, Obamacare: How Trump and Harris could change U.S. health care
Kamala Harris and Donald Trump are both pledging to make health care more affordable in the U.S., but have largely
Read More
Walgreens says it will close 1,200 stores by 2027, as earnings top estimates
The drugstore chain Walgreens said it plans to close roughly 1,200 stores over the next three years, which includes 500
Read More
U.S. FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The agency said it would now allow compounding pharmacies and facilities to provide the drugs while it reviews if there
Read More
Wegovy and Zepbound rival targeting ‘next generation’ of obesity drugs, Zealand Pharma CEO says
Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market dominated
Read More